Gas transfer in isolated lungs perfused with red cell suspension or hemoglobin solutionGEISER, J; BETTICHER, D. C.Respiration physiology. 1989, Vol 77, Num 1, pp 31-39, issn 0034-5687Article

Effect of RBC shape and deformability on pulmonary O₂ diffusing capacity and resistance to flow in rabbit lungsBETTICHER, D. C; REINHART, W. H; GEISER, J et al.Journal of applied physiology (1985). 1995, Vol 78, Num 3, pp 778-783, issn 8750-7587Article

Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patientsBETTICHER, D. C; HEIGHWAY, J; THATCHER, N et al.British journal of cancer. 1997, Vol 75, Num 12, pp 1761-1768, issn 0007-0920Article

Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusionSONDEREGGER, T; BETTICHER, D. C; CERNY, T et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 1, pp 40-42, issn 0344-5704Article

The effect of Rituximab on patients with follicular and mantle-cell lymphomaGHIELMINI, M; SCHMITZ, S.-F. H; CERNY, T et al.Annals of oncology. 2000, Vol 11, pp 123-126, issn 0923-7534, SUP1Conference Paper

Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemiaBETTICHER, D. C; SCHMITZ, S.-F. H; RATSCHILLER, D et al.British journal of haematology. 1997, Vol 99, Num 2, pp 358-363, issn 0007-1048Article

Melanoma : chemotherapyLEE, S. M; BETTICHER, D. C; THATCHER, N et al.British medical bulletin. 1995, Vol 51, Num 3, pp 609-630, issn 0007-1420Article

Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemiaBETTICHER, D. C; HUXOL, H; MÜLLER, R et al.Experimental hematology. 1993, Vol 21, Num 12, pp 1517-1521, issn 0301-472XArticle

Cyclin dl overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survivalRATSCHILLER, D; HEIGHWAY, J; GUGGER, M et al.Journal of clinical oncology. 2003, Vol 21, Num 11, pp 2085-2093, issn 0732-183X, 9 p.Article

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trialROSELL, R; GATZEMEIER, U; ARDIZZONI, A et al.Annals of oncology. 2002, Vol 13, Num 10, pp 1539-1549, issn 0923-7534, 11 p.Article

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerBETTICHER, D. C; HEIGHWAY, J; HASLETON, P. S et al.British journal of cancer. 1996, Vol 73, Num 3, pp 294-300, issn 0007-0920Article

2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphomaBETTICHER, D. C; ZUCCA, E; VON ROHR, A et al.Annals of oncology. 1996, Vol 7, Num 8, pp 793-799, issn 0923-7534Article

High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemiasBETTICHER, D. C; FEY, M. F; ZULIAN, G et al.Annals of oncology. 1994, Vol 5, Num 1, pp 57-64, issn 0923-7534Article

Increased colony growth in peripheral blood cultures from patients with ALL depends on immunological subtypeBETTICHER, D. C; HUXOL, H; MÜLLER, R et al.European journal of haematology. 1993, Vol 51, Num 2, pp 109-112, issn 0902-4441Article

Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II studyJERMANN, M; JOST, L. M; TAVERNA, Ch et al.Annals of oncology. 2004, Vol 15, Num 3, pp 511-516, issn 0923-7534, 6 p.Article

Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumoursGUGGER, M; KAPPELER, A; VONLANTHEN, S et al.Lung cancer. 2001, Vol 33, Num 2-3, pp 229-239, issn 0169-5002Article

p21 is associated with cyclin D1, p16INK4a and pRB expression in resectable non-small cell lung cancerVONLANTHEN, S; HEIGHWAY, J; KAPPELER, A et al.International journal of oncology. 2000, Vol 16, Num 5, pp 951-957, issn 1019-6439Article

G₁ control gene status is frequently altered in resectable non-small cell lung cancerBETTICHER, D. C; WHITE, G. R. M; VONLANTHEN, S et al.International journal of cancer. 1997, Vol 74, Num 5, pp 556-562, issn 0020-7136Article

Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAGHEIGHWAY, J; BETTICHER, D. C; HOBAN, P. R et al.Genomics (San Diego, Calif.). 1996, Vol 35, Num 1, pp 207-214, issn 0888-7543Article

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)JOERGER, M; BATY, F; ROTHSCHILD, S et al.Lung cancer. 2014, Vol 85, Num 2, pp 306-313, issn 0169-5002, 8 p.Article

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma : Results of the international randomized phase III trial (MISTRAL)BETTICHER, D. C; MARTINELLI, G; COGLIATTI, S. B et al.Annals of oncology. 2006, Vol 17, Num 10, pp 1546-1552, issn 0923-7534, 7 p.Article

Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignanciesLAURENCET, F. M; ZULIAN, G. B; GUETTY-ALBERTO, M et al.British journal of cancer. 1999, Vol 79, Num 7-8, pp 1215-1219, issn 0007-0920Article

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancerBORNER, M. M; BROUSSET, P; PFANNER-MEYER, B et al.British journal of cancer. 1999, Vol 79, Num 5-6, pp 952-958, issn 0007-0920Article

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemiaBETTICHER, D. C; RATSCHILLER, D; CERNY, T et al.Annals of oncology. 1998, Vol 9, Num 7, pp 721-726, issn 0923-7534Article

Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine) : demonstration of exogenous DNA in various tissue extracts by PCR analysisZULIAN, G. B; ROUX, E; JEANNET, M et al.British journal of haematology. 1995, Vol 89, Num 1, pp 83-89, issn 0007-1048Article